GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling
GIPC2, a novel exosomal molecule, associated with WNT signaling as a potential therapeutic target, is a putative unique epigenetic oncogene in the prostate cancer metastasis.